Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03739268
What this trial is testing

GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration

Who this might be right for
Type 2 Diabetes Mellitus
Steno Diabetes Center Copenhagen 17
Large-scale testing (Phase 3)Study completedNCT02423824
What this trial is testing

Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
University Health Network, Toronto 21
Large-scale testing (Phase 3)Study completedNCT04039503
What this trial is testing

Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 475
Not applicableActive Not RecruitingNCT07649759
What this trial is testing

Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity

Who this might be right for
Obesity & OverweightEmotional Eating BehaviourMindful Eating Intervention
Bern University of Applied Sciences 40
Not applicableStudy completedNCT00716170
What this trial is testing

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Who this might be right for
Type 2 Diabetes Mellitus
Herlev Hospital 10
Not applicableStudy completedNCT06034457
What this trial is testing

Testing the Effectiveness of WW Clinic GLP1

Who this might be right for
Weight LossObesity
The Cleveland Clinic 180
Not applicableStudy completedNCT03056677
What this trial is testing

Modified Whey Protein and Effect on Post Meal Glucose Levels Study

Who this might be right for
Metabolism Disorder, Glucose
University of Aberdeen 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07731256
What this trial is testing

Semaglutide for Low Back Pain

Who this might be right for
Lower Back PainObesity (BMI>30)Chronic Lower Back Pain+1 more
Washington University School of Medicine 250
Large-scale testing (Phase 3)Looking for participantsNCT05569772
What this trial is testing

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Who this might be right for
Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven 252
Not applicableNot Yet RecruitingNCT07770737
What this trial is testing

Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular DiseasesStage B Heart Failure
Dongtan Sacred Heart Hospital 100
Post-approval studies (Phase 4)Study completedNCT01219400
What this trial is testing

Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes

Who this might be right for
Diabetes
Lund University 28
Post-approval studies (Phase 4)Study completedNCT03101930
What this trial is testing

Cardiovascular Effects of GLP-1 Receptor Activation

Who this might be right for
ObesityPreDiabetes
Vanderbilt University Medical Center 329
Post-approval studies (Phase 4)Study completedNCT02639130
What this trial is testing

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 67
Large-scale testing (Phase 3)Not Yet RecruitingNCT07021937
What this trial is testing

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Who this might be right for
Obesity/Therapy
University of Colorado, Denver 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331
What this trial is testing

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Who this might be right for
Hormone-receptor-positive Breast CancerEarly Breast Cancer
Universitaire Ziekenhuizen KU Leuven 168
Early research (Phase 1)Study completedNCT01405261
What this trial is testing

Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 101
Early research (Phase 1)Looking for participantsNCT07628127
What this trial is testing

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight
Verdiva Bio Dev Limited 336
Post-approval studies (Phase 4)Study completedNCT04876027
What this trial is testing

GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary Syndrome
Shanghai 10th People's Hospital 68
Not applicableStudy completedNCT04610203
What this trial is testing

Glycaemic Response, Insulinaemic Response, GLP-1 and GIP Testing of Food Product Lines

Who this might be right for
Healthy
Oxford Brookes University 41
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630454
What this trial is testing

Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Who this might be right for
Atrial FibrillationHeart Failure With Preserved Ejection Fraction (HFpEF)Tirzepatide
Yunlong Wang 602
Next Page